NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 175 filers reported holding NEVRO CORP in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $800,730 | -79.3% | 31,500 | -70.6% | 0.00% | -85.7% |
| Q1 2023 | $3,868,050 | -23.7% | 107,000 | -16.4% | 0.02% | -16.0% |
| Q4 2022 | $5,068,800 | +105.2% | 128,000 | +141.5% | 0.02% | +108.3% |
| Q3 2022 | $2,470,000 | -25.2% | 53,000 | +30.2% | 0.01% | +71.4% |
| Q4 2021 | $3,300,000 | +115.0% | 40,700 | +270.0% | 0.01% | +75.0% |
| Q1 2021 | $1,535,000 | -79.4% | 11,000 | -74.4% | 0.00% | -80.0% |
| Q4 2020 | $7,443,000 | +385.8% | 43,000 | +290.9% | 0.02% | +81.8% |
| Q3 2020 | $1,532,000 | +16.6% | 11,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,314,000 | -67.7% | 11,000 | -68.2% | 0.01% | -35.3% |
| Q4 2019 | $4,067,000 | – | 34,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |